You searched for "AMM"

1961 results found

BEECS (British Emergency Eye Care Society) Annual Meeting 2025

British Emergency Eye Care SocietyWelcome to BEECSThe Society was founded in 2013 with the aim of bringing together practitioners in the United Kingdom who provide acute ophthalmology services within their institutions. We run an annual scientific meeting open to all...

Macular Society chief executive, Cathy Yelf, announces retirement

After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.

At least 70 percent of cataract patients could benefit from toric IOL

More than two-thirds of cataract patients could benefit from toric intraocular lenses (IOL), according to findings presented at 100% Optical. Consultant ophthalmologist Nigel Kirkpatrick set out how astigmatism is a significant issue for cataract surgery patients during a main stage...

Optegra announces programme of engaging CPD events for healthcare community

Optegra continues to strengthen its commitment to clinical excellence and community partnership by announcing a series of Continuing Professional Development (CPD) events throughout 2026, open to any health care professionals in optometry. Taking place across a range of dates and...

WVUK (Women in Vision) Winter Meeting 2023

December 2, 2022, brought together Women in Vision UK (WVUK) members for their winter meeting. WVUK is a membership organisation focussed on gender equality in vision-related sciences and healthcare. This year’s winter meeting was held in Moorfields Education Hub and...

AI breakthrough brings geographic atrophy treatment a step closer

A team led by Dr Konstantinos Balaskas at Moorfields Eye Hospital Reading Centre has developed a fully automated, deep-learning model (algorithm) that can detect and quantify geographic atrophy using standard optical coherence tomography (OCT) scans.

How many injections in nAMD: ranibizumab vs. aflibercept

Intravitreal anti-VEGF injections make up a large proportion of the workload in ophthalmology clinics. Since the introduction of aflibercept with eight weekly injections there has been an option to use a treatment which may require less treatment, with potential cost...

Macular pigment and dark adaptation in older population with normal maculas

Macular pigment (MP) such as lutein, zeaxanthin and meso-zeaxanthin are highly concentrated in the fovea. They protect the retina from damage of ambient blue light via antioxidant properties. In older eyes with normal healthy retina, macular pigment optical density (MPOD)...

Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?

There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...

Comparing femtosecond laser assisted-DMEK to manual DMEK

Femtosecond laser is as a novel tool for performing precise descemetorhexis in descemet membrane endothelial keratoplasty (DMEK) surgery. In DMEK surgery, the recipient’s Descemet membrane is peeled to allow adherence of the donor DMEK tissue to the recipient’s stroma. Complete...

Risk stratification to reduce intraoperative cataract surgical complications

The authors prospectively collected data on 1135 consecutive patients undergoing cataract surgery. They were risk stratified according to categories – A (no additional risk factors, 0 points), B (vitrectomy, corneal scarring, small pupil less than 3mm, shallow anterior chamber less...

VIBIM Study: One-year results of treatment of DME with aflibercept using TnE

The VIBIM study (the treat-and-extend regimen (TER) using intravitreal aflibercept in diabetic macular edema (DME) study) was designed to evaluate the efficacy of the TER using aflibercept in the management of DME for a period of two years. The authors...